• Applied Bortezomib (PS-341) Workflows: Proteasome Inhibition

  2026-05-25

  Bortezomib (PS-341) stands out in both cancer and metabolic research as a benchmark proteasome inhibitor, enabling precise regulation of apoptosis and cellular proteostasis. This article details optimized workflows, troubleshooting strategies, and protocol enhancements—bridging recent advances in mitochondrial protein turnover with robust oncology assay design.

• Biomimetic Chromatography for Modeling Lung Drug Permeabilit

  2026-05-25

  This study introduces and rigorously evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane liquid chromatography (IAM-LC), both coupled with mass spectrometry, for predicting pulmonary drug permeability. The findings offer robust, high-throughput alternatives to conventional models, with direct implications for optimizing anti-inflammatory corticosteroid workflows in respiratory disease research.

• Exemestane in Translational Endocrine Research: Mechanism, P

  2026-05-24

  Discover how Exemestane, a steroidal aromatase inhibitor, enables precise estrogen biosynthesis inhibition in hormone research. This in-depth guide uniquely bridges molecular pharmacology with translational assay protocols, offering practical insights for advanced breast cancer research.

• 4-Hydroxytamoxifen: Technical Guidance for Research Workflow

  2026-05-23

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator specifically designed for research protocols that require strict DMSO solubility, such as in breast cancer, prostate cancer, and cardiac myocyte studies. It is unsuitable for workflows needing aqueous or ethanol solubility, and its handling demands precise storage and preparation to maintain experimental integrity.

• SARS-CoV-2 N Protein Disrupts GADD34-Mediated Innate Immunit

  2026-05-22

  This study uncovers how the SARS-CoV-2 nucleocapsid protein impairs host innate immune defense by sequestering GADD34 mRNA into atypical stress granule-like foci, hindering interferon signaling. The findings clarify a previously uncharacterized viral immune evasion mechanism with implications for antiviral and stress granule research.

• Hypothalamic Gene Expression in Caged vs Cage-Free Laying He

  2026-05-22

  This study applied transcriptomic analysis to reveal how commercial housing systems—caged versus cage-free—distinctly influence hypothalamic gene expression in laying hens under tropical conditions. The findings highlight key molecular pathways affected by housing, offering new genetic markers for welfare assessment beyond traditional physiological indicators.

• Vernakalant Hydrochloride: Ion Channel Blockade in AF Therap

  2026-05-21

  Vernakalant Hydrochloride (RSD1235) is an atrial-selective antiarrhythmic agent that rapidly converts atrial fibrillation to sinus rhythm by targeting specific cardiac ion channels. Its unique pharmacological profile offers high efficacy and minimal ventricular side effects, as supported by quantitative clinical and mechanistic evidence.

• Lisinopril Dihydrate: Advanced ACE Inhibition & Peptidase Se

  2026-05-21

  Explore the scientific nuances of Lisinopril dihydrate as a long-acting ACE inhibitor, focusing on its enzymatic selectivity and practical implications for hypertension research. This article uniquely bridges reference-driven insights on peptidase targeting with actionable assay recommendations.

• Dinaciclib Exploits VHL Deficiency in Clear Cell Renal Carci

  2026-05-20

  The referenced study demonstrates that the cyclin-dependent kinase inhibitor Dinaciclib selectively targets clear cell renal cell carcinoma (CC-RCC) with VHL deficiency, exploiting synthetic lethality for improved tumor specificity. These findings highlight a promising therapeutic window for CC-RCC and offer new avenues for the design of precision-targeted cancer treatments.

• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-05-20

  Clodronate Liposomes from APExBIO deliver highly selective in vivo macrophage depletion, enabling researchers to dissect immune cell function in complex disease models. This guide bridges cutting-edge reference data and actionable workflows, empowering researchers to optimize immune modulation strategies with confidence.

• Structure-Based Screening of Natural Products Targeting SARS

  2026-05-19

  This study uses structure-based virtual screening to identify natural product inhibitors of SARS-CoV-2 NSP15, highlighting thymopentin and oleuropein as potent candidates. The research demonstrates the application of computational methods for antiviral drug discovery and provides insights into NSP15 as a target for modulating viral immune evasion.

• Applied Workflows with Tofacitinib Citrate in Immune Regulat

  2026-05-19

  Tofacitinib citrate (CP-690550 citrate) offers nanomolar-selective JAK3 inhibition, empowering immune regulation and inflammatory disorder research with precise pathway modulation. This guide translates the latest vascular effect insights and protocol advances into actionable workflows, troubleshooting, and optimization strategies for the modern bench scientist.

• Ionophore Toxicity in Animals: Mechanisms and Tiamulin Inter

  2026-05-18

  This review synthesizes current knowledge of ionophore toxicity in animals, emphasizing both clinical manifestations and molecular mechanisms. Notably, it explores how tiamulin (thiamutilin), a pleuromutilin antibiotic, interacts with ionophores, affecting their metabolism and toxicity profiles—key considerations for veterinary and translational research.

• 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture:

  2026-05-18

  This article explores real-world laboratory scenarios where the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041) from APExBIO delivers reproducible, high-sensitivity results for cell viability, proliferation, and DNA synthesis workflows. Scenario-driven Q&As guide biomedical researchers and lab technicians through evidence-based best practices, with protocol precision and vendor reliability at the forefront.

• Stereochemical Modifications in GnRH Antagonists: Activity I

  2026-05-17

  This study explores how substituting position 3 in degarelix with racemic 3-(2-methoxy-5-pyridyl)-alanine affects GnRH antagonist potency and duration. The findings reveal a pronounced impact of stereochemistry on receptor antagonism, with direct implications for peptide drug design and hormonal pathway modulation.

466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page